메뉴 건너뛰기




Volumn 3, Issue 6, 2001, Pages 386-397

Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: Focus on β-adrenergic blockade

Author keywords

Adrenergic antagonists; Adverse effects; Eye; Glaucoma; Intraocular pressure

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ANTIGLAUCOMA AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; CARBACHOL; CARTEOLOL; DICLOFENAMIDE; DILTIAZEM; DIPIVEFRINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; DYFLOS; ECOTHIOPATE; LATANOPROST; LEVOBETAXOLOL; LEVOBUNOLOL; METHAZOLAMIDE; METIPRANOLOL; MIOTIC AGENT; OSMOTIC AGENT; PILOCARPINE; PROPRANOLOL; TIMOLOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNOPROSTONE ISOPROPYL ESTER; VERAPAMIL;

EID: 0035661823     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200111000-00007     Document Type: Review
Times cited : (52)

References (147)
  • 1
    • 0007471186 scopus 로고    scopus 로고
    • Glaucoma Research Foundation [Web site]
  • 10
    • 0030827597 scopus 로고    scopus 로고
    • Systemic adverse effects of topical ophthalmic agents. Implications for older patients
    • (1997) Drugs Aging , vol.11 , pp. 352-360
    • Diamond, J.P.1
  • 13
    • 17544403813 scopus 로고    scopus 로고
    • Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocural pressure and perimetry findings and evaluation of their ocular and systemic effects
    • (2000) J Glaucoma , vol.9 , pp. 45-50
    • Mirza, G.E.1    Karakucuk, S.2    Temel, E.3
  • 20
    • 0018601266 scopus 로고
    • Clinical pharmacology of the new beta-adrenergic blocking drugs. I. Pharmacodynamic and pharmacokinetic properties
    • (1979) Am Heart J , vol.97 , pp. 663-670
    • Frishman, W.H.1
  • 30
    • 0024566628 scopus 로고
    • Pharmacologic effects of beta blocking agents used in the management of glaucoma
    • (1989) Surv Ophthalmol , vol.33 , pp. 453-454
    • James, I.M.1
  • 37
    • 0032419841 scopus 로고    scopus 로고
    • Efficacy and tolerability of 0.5% timolol maleate gel-forming forming solution QD compared with 0.5% levobunolol hydrochloride B1D in patients with open-angle glaucoma or ocular hypertension
    • (1998) Clin Ther , vol.20 , pp. 1170-1178
    • Walters, T.R.1    Maloney, S.2    Slater, D.3
  • 53
    • 0019794841 scopus 로고
    • 2-adrenoceptors in guinea pig and human lung
    • (1981) Postgrad Med J , vol.57 , Issue.SUPPL. 1 , pp. 77-83
    • Engel, G.1
  • 59
    • 0029078347 scopus 로고
    • Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents
    • (1995) Lancet , vol.345 , pp. 1604-1606
    • Diggory, P.1    Cassels, B.A.2    Vail, A.3
  • 60
    • 0027431911 scopus 로고
    • Improved lung function tests on changing from topical timolol: Non-selective beta-blockade impairs lung function tests in elderly patients
    • (1993) Eye , vol.7 , Issue.PART 5 , pp. 661-663
    • Diggory, P.1    Heyworth, P.2    Chau, G.3
  • 69
    • 0021998457 scopus 로고
    • Levobunolol: A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma
    • (1985) Ophthalmology , vol.92 , pp. 1271-1276
  • 71
    • 0024560657 scopus 로고
    • Levobunolol: A four-year study of efficacy and safety in glaucoma treatment
    • (1989) Ophthalmology , vol.96 , pp. 642-645
  • 81
    • 0023768246 scopus 로고
    • Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties. I. Therapeutic efficacy in glaucoma and ocular hypertension
    • (1988) Drugs , vol.36 , pp. 601-615
    • Battershill, P.E.1    Sorkin, E.M.2
  • 83
    • 0000959147 scopus 로고
    • Efficacy and tolerance of metipranolol. Results of a multicenter long-term study
    • Merte HJ (ed). New York: Springer-Verlag
    • (1983) Metipranolol , pp. 121-125
    • Denffer, H.1
  • 86
    • 0026444468 scopus 로고
    • Ocular carteolol: A review of its pharmacological properties and therapeutic use in glaucoma and ocular hypertension
    • (1992) Drugs Aging , vol.2 , pp. 58-77
    • Chrisp, P.1    Sorkin, E.M.2
  • 88
    • 0026444468 scopus 로고
    • Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension
    • published erratum appears in Drugs Aging 1994;4:62
    • (1992) Drugs Aging , vol.2 , pp. 58-77
    • Chrisp, P.1    Sorkin, E.M.2
  • 95
  • 96
    • 0029964911 scopus 로고    scopus 로고
    • Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people
    • (1996) Age Ageing , vol.25 , pp. 424-428
    • Diggory, P.1    Cassels, B.A.2    Fernandez, C.3
  • 100
  • 106
    • 9444251055 scopus 로고    scopus 로고
    • The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients
    • (1996) J Glaucoma , vol.5 , pp. 252-257
    • Yamamoto, T.1    Kitazawa, Y.2    Noma, A.3
  • 107
    • 39449127397 scopus 로고
    • Mydriatics, cycloplegics, local anesthetics, and intraocular miotics
    • Chicago: American Medical Association
    • (1995) AMA Drug Evaluations , pp. 2249
  • 113
    • 0025559665 scopus 로고
    • Apraclonidine hydrochloride: An evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardio-vascular effects to timolol maleate
    • (1990) Trans Am Ophthalmol Soc , vol.88 , pp. 149-159
    • Robin, A.L.1    Coleman, A.L.2
  • 114
    • 0031886692 scopus 로고    scopus 로고
    • Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension
    • (1998) Drugs Aging , vol.12 , pp. 225-241
    • Adkins, J.C.1    Balfour, J.A.2
  • 115
    • 0030908739 scopus 로고    scopus 로고
    • Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension
    • (1997) Drugs Aging , vol.10 , pp. 384-403
    • Balfour, J.A.1    Wilde, M.I.2
  • 117
    • 0033990833 scopus 로고    scopus 로고
    • Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors
    • (2000) Prog Retina Eye Res , vol.19 , pp. 87-112
    • Sugrue, M.F.1
  • 123
    • 0033975428 scopus 로고    scopus 로고
    • The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension
    • The Brinzolamide Long-Term Therapy Study Group
    • (2000) Am J Ophthalmol , vol.129 , pp. 136-143
    • March, W.F.1    Ochsner, K.I.2
  • 125
    • 0030808702 scopus 로고    scopus 로고
    • Dorzolamide: Development and clinical application of a topical carbonic anhydrase inhibitor
    • (1997) Surv Ophthalmol , vol.42 , pp. 137-151
    • Pfeiffer, N.1
  • 127
    • 0027732298 scopus 로고
    • Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension
    • (1993) Jpn J Ophthal , vol.37 , pp. 514-525
    • Azuma, J.1    Masuda, K.2    Kitazawa, Y.3
  • 128
  • 129
    • 9044238840 scopus 로고    scopus 로고
    • A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension
    • The Latanoprost Study Group
    • (1996) Ophthalmology , vol.103 , pp. 126-137
    • Watson, P.1    Stjernschantz, J.2
  • 130
    • 0029844173 scopus 로고    scopus 로고
    • Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients
    • Latanoprost Study Groups
    • (1996) Ophthalmology , vol.103 , pp. 1916-1924
    • Camras, C.B.1    Alm, A.2    Watson, P.3
  • 131
    • 0030023938 scopus 로고    scopus 로고
    • Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month masked, multicenter trial in the United States
    • The United States Latanoprost Study Group
    • (1996) Ophthalmology , vol.103 , pp. 138-147
    • Camras, C.B.1
  • 141
    • 0031795381 scopus 로고    scopus 로고
    • A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide
    • Dorzolamide-Timolol Combination Study Group
    • (1998) Ophthalmology , vol.105 , pp. 1952-1959
    • Clineschmidt, C.M.1    Williams, R.D.2    Snyder, E.3
  • 143
    • 0031767420 scopus 로고    scopus 로고
    • The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components
    • Dorzolamide-Timolol Study Group [see comments]
    • (1998) Ophthalmology , vol.105 , pp. 1936-1944
    • Strohmaier, K.1    Snyder, E.2    DuBiner, H.3
  • 146
    • 0028809608 scopus 로고
    • Pharmacogenetic explanation for excessive beta blockade following timolol eye drops: Potential for oral-ophthalmic drug interaction
    • (1995) JAMA , vol.274 , pp. 1611-1613
    • Edeki, T.I.1    He, H.2    Wood, A.J.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.